Juming Lu

7.2k total citations · 1 hit paper
94 papers, 4.3k citations indexed

About

Juming Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Juming Lu has authored 94 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Juming Lu's work include Diabetes Treatment and Management (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers) and Diabetes Management and Research (26 papers). Juming Lu is often cited by papers focused on Diabetes Treatment and Management (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers) and Diabetes Management and Research (26 papers). Juming Lu collaborates with scholars based in China, United States and Philippines. Juming Lu's co-authors include Jianping Weng, Weiping Jia, Haoming Tian, Zhiguang Zhou, Wenying Yang, Linong Ji, Lixiang Lin, Qiuhe Ji, Zhongyan Shan and Jianzhong Xiao and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Juming Lu

93 papers receiving 4.2k citations

Hit Papers

Prevalence of Diabetes among Men and Women in China 2010 2026 2015 2020 2010 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juming Lu China 24 2.1k 1.0k 774 711 629 94 4.3k
Qiuhe Ji China 24 2.0k 0.9× 1.0k 1.0× 816 1.1× 600 0.8× 535 0.9× 75 4.2k
Jianzhong Xiao China 19 1.6k 0.8× 864 0.9× 716 0.9× 598 0.8× 543 0.9× 63 3.9k
Stavroula Α. Paschou Greece 37 1.6k 0.8× 911 0.9× 637 0.8× 732 1.0× 481 0.8× 200 4.7k
Dorte Vistisen Denmark 35 2.4k 1.1× 733 0.7× 706 0.9× 645 0.9× 581 0.9× 128 4.3k
Ho‐Young Son South Korea 27 1.9k 0.9× 601 0.6× 665 0.9× 795 1.1× 476 0.8× 85 3.7k
Manouchehr Nakhjavani Iran 33 1.7k 0.8× 913 0.9× 1.1k 1.4× 568 0.8× 732 1.2× 232 4.5k
Xuefeng Yu China 36 1.6k 0.7× 766 0.8× 979 1.3× 585 0.8× 664 1.1× 139 4.5k
Jan Erik Henriksen Denmark 42 1.9k 0.9× 1.3k 1.2× 560 0.7× 705 1.0× 670 1.1× 128 4.6k
Carlos Lorenzo United States 35 2.0k 0.9× 943 0.9× 1.1k 1.4× 517 0.7× 567 0.9× 86 4.1k
Marília Brito Gomes Brazil 33 2.3k 1.1× 798 0.8× 568 0.7× 739 1.0× 604 1.0× 217 4.5k

Countries citing papers authored by Juming Lu

Since Specialization
Citations

This map shows the geographic impact of Juming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juming Lu more than expected).

Fields of papers citing papers by Juming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juming Lu. The network helps show where Juming Lu may publish in the future.

Co-authorship network of co-authors of Juming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Juming Lu. A scholar is included among the top collaborators of Juming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juming Lu. Juming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Juming, Yan Li, Li Qin, et al.. (2021). Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial. Diabetes Obesity and Metabolism. 23(5). 1111–1120. 16 indexed citations
3.
Dou, Jingtao, Deqiang Zheng, Jie Zhang, et al.. (2020). <p>Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 4651–4659. 5 indexed citations
5.
Li, Jing, Yingying Luo, Xiaohui Guo, et al.. (2017). Long exposure to type 2 diabetes and risk of non-fatal coronary heart disease in Chinese females and males: Findings from a China national cross-sectional study. Diabetes Research and Clinical Practice. 137. 119–127. 1 indexed citations
6.
Li, Ming, et al.. (2016). Disproportionately Elevated Proinsulin Levels as an Early Indicator ofβ-Cell Dysfunction in Nondiabetic Offspring of Chinese Diabetic Patients. International Journal of Endocrinology. 2016. 1–9. 7 indexed citations
7.
Ji, Linong, Puhong Zhang, Jianping Weng, et al.. (2015). Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China—Study Design and Baseline Characteristics. Diabetes Technology & Therapeutics. 17(10). 735–744. 33 indexed citations
8.
Zhang, Lihua, Linong Ji, Lixin Guo, et al.. (2015). Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China. Diabetes Technology & Therapeutics. 17(11). 816–824. 11 indexed citations
9.
Sun, Qi‐Hong, Kang Chen, Wenhua Yan, et al.. (2015). Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study. Clinical and Experimental Medicine. 17(1). 85–91. 6 indexed citations
10.
Guo, Qinghua, Juming Lu, Yiming Mu, et al.. (2014). Analysis of three patients with adult idiopathic isolated ACTH deficiency and literature review. Zhonghua neifenmi daixie zazhi. 30(1). 38–42. 1 indexed citations
11.
Ji, Linong, Xinyue Zhi, Juming Lu, et al.. (2014). Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China. PLoS ONE. 9(8). e103507–e103507. 2 indexed citations
13.
Yang, Wenying, Jie Liu, Zhongyan Shan, et al.. (2013). Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. The Lancet Diabetes & Endocrinology. 2(1). 46–55. 128 indexed citations
14.
Zhou, Zhichao, Jingtao Dou, Jianming Ba, et al.. (2012). Investigation on evaluation of pituitary function after transsphenoidal ectomy of hypophysoma. Zhonghua neifenmi daixie zazhi. 28(7). 542–545. 1 indexed citations
15.
Chen, Min, Jingtao Dou, Xianling Wang, et al.. (2012). Insulin autoimmune syndrome: An analysis of clinical features, following up data, and review of literature. Zhonghua neifenmi daixie zazhi. 28(10). 813–816. 1 indexed citations
16.
Lu, Yanhui, Juming Lu, Chunlin Li, et al.. (2012). Cognitive function with glucose tolerance status and obesity in Chinese middle-aged and aged adults. Aging & Mental Health. 16(7). 911–914. 12 indexed citations
17.
Wang, Xianling, et al.. (2012). Chronic inflammatory demyelinating polyneuropathy mimicking diabetic neuropathy in a young female with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 96(2). e15–e17. 4 indexed citations
18.
Lv, Zhaohui, Jing Du, Guoqing Yang, et al.. (2011). Significance of thyrotrophic receptor antibody(TRAb) in clinical diagnosis of Graves’ disease. Jiefangjun yixue zazhi. 36(5). 501–504. 1 indexed citations
19.
Lu, Yanhui, Juming Lu, Shuyu Wang, et al.. (2011). Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Advances in Therapy. 28(6). 511–519. 23 indexed citations
20.
Gong, Yuping, Baoan Wang, Lijuan Yang, et al.. (2009). Clinical and epigenetic study of a case with adrenal hypoplasia congenita caused by a novel DAX-1 gene mutation. Zhonghua neifenmi daixie zazhi. 25(1). 62–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026